John K. Cini
CIK 1806526 · Chief Scientific Officer · last filed 2025-12-03
John K. Cini is a Chief Scientific Officer who has filed 9 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for SONN, was dated Dec 3, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
9
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Chief Scientific Officer | 0 | $1.26 | $0 | $0 | 9 | 2025-12-03 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-03 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Disp (D) | −14,116 | $0 | EDGAR |
| 2025-07-15 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +12,000 | $0 | EDGAR |
| 2024-12-05 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +1,888 | $0 | EDGAR |
| 2023-02-17 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Mixed | — | $0 | EDGAR |
| 2022-12-22 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +18,551 | $0 | EDGAR |
| 2022-04-08 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +80,034 | $0 | EDGAR |
| 2021-05-28 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Tax (F) | −14,004 | -$21.1K | EDGAR |
| 2020-07-02 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +78,214 | $0 | EDGAR |
| 2020-04-03 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +159,857 | $0 | EDGAR |